Precision Neuroscience Corp — SEC Form D Filing

Precision Neuroscience Corp filed an SEC Form D on September 28, 2026, reporting $250.00M raised in Medical Devices.

Form D filing details

Filing
SEC Form D
Filing date
September 28, 2026
Amount reported
$250.00M
Round stage
Series B+
Industry
Medical Devices
Website
https://www.precisionneuro.io/

What the company does

Securities: Equity. Exemption: Rule 506(b). Incorporated: DELAWARE

Problem

Millions of people suffer from paralysis, which limits their ability to interact with digital devices and can lead to a loss of independence and connection. They are currently unable to operate digital devices using only their thoughts.

Solution

Precision Neuroscience is developing Layer 7, a high-bandwidth brain-computer interface that allows individuals with paralysis to operate digital devices using only their thoughts, achieved without harm.

Why now

Advances in neural interface technology and miniaturization, coupled with increasing demand for assistive technologies, make high-bandwidth, less invasive brain-computer interfaces viable for clinical application today.

Verdict

Investors backed a substantial bet on a less invasive, high-bandwidth BCI approach because it significantly broadened the addressable patient population beyond what fully implanted devices could credibly reach, not because of demonstrated clinical efficacy or broad regulatory approvals. This cleared given the scale of the potential market, assuming a clear path to high-volume manufacturing and reimbursement could be charted. The trade-off was accepting a longer, more capital-intensive development cycle compared to more immediate, niche surgical solutions already in trials.

Source: SEC EDGAR Form D filing